Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy.
Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy.
复制标题
DOI:
10.1016/j.gendis.2022.12.008
复制
发表时间:
2024-01
期刊:
影响因子:
6.8
通讯作者:
Wang, Ping
中科院分区:
文献类型:
--
作者:
Zhao, Pengcheng;Xie, Longyan;Yu, Lei;Wang, Ping
The interaction between cluster of differentiation 47 (CD47) and signal regulatory protein α (SIRPα) protects healthy cells from macrophage attack, which is crucial for maintaining immune homeostasis. Overexpression of CD47 occurs widely across various tumor cell types and transmits the “don't eat me” signal to macrophages to avoid phagocytosis through binding to SIRPα. Blockade of the CD47-SIRPα axis is therefore a promising approach for cancer treatment. Lymphoma is the most common hematological malignancy and is an area of unmet clinical need. This review mainly described the current strategies targeting the CD47-SIRPα axis, including antibodies, SIRPα Fc fusion proteins, small molecule inhibitors, and peptides both in preclinical studies and clinical trials with Hodgkin lymphoma and non-Hodgkin lymphoma.
登录
查看更多内容
影响因子:
11.2
作者:
Chao MP;Alizadeh AA;Tang C;Jan M;Weissman-Tsukamoto R;Zhao F;Park CY;Weissman IL;Majeti R
通讯作者:
Majeti R
影响因子:
2.2
作者:
Chen Y;Li M;Cao J;Cai G;Li X;Liu Y;Chen W
通讯作者:
Chen W
影响因子:
32.4
作者:
Dersh D;Phelan JD;Gumina ME;Wang B;Arbuckle JH;Holly J;Kishton RJ;Markowitz TE;Seedhom MO;Fridlyand N;Wright GW;Huang DW;Ceribelli M;Thomas CJ;Lack JB;Restifo NP;Kristie TM;Staudt LM;Yewdell JW
通讯作者:
Yewdell JW
DOI:
10.1177/0300060518799612
发表时间:
2018-11
期刊:
The Journal of international medical research
影响因子:
--
作者:
Zhang J;Jin S;Guo X;Qian W
通讯作者:
Qian W
影响因子:
10.9
作者:
Chauchet, Xavier;Cons, Laura;Chatel, Laurence;Daubeuf, Bruno;Didelot, Gerard;Moine, Valery;Chollet, Didier;Malinge, Pauline;Pontini, Guillemette;Masternak, Krzysztof;Ferlin, Walter;Buatois, Vanessa;Shang, Limin
通讯作者:
Shang, Limin